A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials
- 27 February 2019
- journal article
- research article
- Published by Springer Nature in Journal of Mammary Gland Biology and Neoplasia
- Vol. 24 (2) , 149-162
Abstract
In order to develop a practical model of breast cancer, with in vitro and syngeneic, immune-intact, in vivo growth capacity, we established a primary cell line derived from a mammary carcinoma in the transgenic FVB/N-Tg(MMTV-ErbB2*)NDL2-5Mul mouse, referred to as “NDLUCD”. The cell line is adapted to standard cell culture and can be transplanted into syngeneic FVB/N mice. The line maintains a stable phenotype over multiple in vitro passages and rounds of in vivo transplantation. NDLUCD tumors in FVB/N mice exhibit high expression of ErbB2 and ErbB3 and signaling molecules downstream of ErbB2. The syngeneic transplant tumors elicit an immune reaction in the adjacent stroma, detected and characterized using histology, immunophenotyping, and gene expression. NDLUCD cells also express PD-L1 in vivo and in vitro, and in vivo transplants are reactive to anti-immune checkpoint therapy with responses conducive to immunotherapy studies. This new NDLUCD cell line model is a practical alternative to the more commonly used 4T1 cells, and our previously described FVB/N-Tg(MMTV-PyVT)634Mul derived Met-1fvb2 and FVB/NTg(MMTV-PyVTY315F/Y322F) derived DB-7fvb2 cell lines. The NDLUCD cells have, so far, remained genetically and phenotypically stable over many generations, with consistent and reproducible results in immune intact preclinical cohorts.Keywords
Funding Information
- National Cancer Institute (U01 CA196406, U01 CA141582, P30CA093373)
This publication has 61 references indexed in Scilit:
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and CufflinksNature Protocols, 2012
- STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomasBreast Cancer Research, 2012
- Choosing a Mouse Model: Experimental Biology in Context--The Utility and Limitations of Mouse Models of Breast CancerCold Spring Harbor Perspectives in Biology, 2011
- A Compendium of the Mouse Mammary Tumor Biologist: From the Initial Observations in the House Mouse to the Development of Genetically Engineered MiceCold Spring Harbor Perspectives in Biology, 2010
- A framework for oligonucleotide microarray preprocessingBioinformatics, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- Accurate whole human genome sequencing using reversible terminator chemistryNature, 2008
- Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast CancerCancer Research, 2008
- Cancer-related inflammationNature, 2008